A citation-based method for searching scientific literature

Xiubing Zhang, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang, Shumin Lu, Li Liang, Jinxia Liu, Buyou Chen, Weidong Shi. Pathol Res Pract 2016
Times Cited: 24







List of co-cited articles
155 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage.
Naoe Taira, Keishi Nihira, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. Mol Cell 2007
210
70

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.
Naoe Taira, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Yoshio Miki, Kiyotsugu Yoshida. J Clin Invest 2012
94
62

DYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading Snail.
Rei Mimoto, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe, Ken Uchida, Yoshio Miki, Kiyotsugu Yoshida. Cancer Lett 2013
53
58


DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
Noriko Yamaguchi, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto, Kiyotsugu Yoshida. Tumour Biol 2015
28
45

Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Haiyan Yan, Kaishun Hu, Wenjing Wu, Yu Li, Huan Tian, Zhonghua Chu, H Phillip Koeffler, Dong Yin. PLoS One 2016
20
55

Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation.
Hae-Yun Jung, Xin Wang, Sohee Jun, Jae-Il Park. J Biol Chem 2013
45
41

DYRK2 expression may be a predictive marker for chemotherapy in non-small cell lung cancer.
Shin-ichi Yamashita, Masao Chujo, Toshihiko Moroga, Kentaro Anami, Keita Tokuishi, Michiyo Miyawaki, Yozo Kawano, Shinsuke Takeno, Satoshi Yamamoto, Katsunobu Kawahara. Anticancer Res 2009
27
41

ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in the apoptotic response to DNA damage.
Naoe Taira, Hiroyuki Yamamoto, Tomoko Yamaguchi, Yoshio Miki, Kiyotsugu Yoshida. J Biol Chem 2010
51
41

Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Daisuke Ito, Satomi Yogosawa, Rei Mimoto, Shinichi Hirooka, Takashi Horiuchi, Ken Eto, Katsuhiko Yanaga, Kiyotsugu Yoshida. Cancer Sci 2017
20
50

Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Moisés Pérez, Carmen García-Limones, Inés Zapico, Anabel Marina, M Lienhard Schmitz, Eduardo Muñoz, Marco A Calzado. J Mol Cell Biol 2012
44
41

Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
Shunichiro Nomura, Yasutomo Suzuki, Ryo Takahashi, Mika Terasaki, Ryoji Kimata, Yasuhiro Terasaki, Tsutomu Hamasaki, Go Kimura, Akira Shimizu, Yukihiro Kondo. BMC Urol 2015
17
52

Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer.
Yasuko Enomoto, Shin-ichi Yamashita, Yasuteru Yoshinaga, Yasuyoshi Fukami, So Miyahara, Kazuki Nabeshima, Akinori Iwasaki. Tumour Biol 2014
23
39

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Charles T Miller, Sanjeev Aggarwal, Theodore K Lin, Susan L Dagenais, Jorge I Contreras, Mark B Orringer, Thomas W Glover, David G Beer, Lin Lin. Cancer Res 2003
46
33


Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer.
R Mimoto, Y Imawari, S Hirooka, H Takeyama, K Yoshida. Oncogene 2017
22
31

Engagement of DYRK2 in proper control for cell division.
Naoe Taira Nihira, Kiyotsugu Yoshida. Cell Cycle 2015
27
29

Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
Shiho Yokoyama-Mashima, Satomi Yogosawa, Yumi Kanegae, Shinichi Hirooka, Saishu Yoshida, Takashi Horiuchi, Toya Ohashi, Katsuhiko Yanaga, Masayuki Saruta, Tsunekazu Oikawa,[...]. Cancer Lett 2019
16
43

Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.
Xing Guo, Xiaorong Wang, Zhiping Wang, Sourav Banerjee, Jing Yang, Lan Huang, Jack E Dixon. Nat Cell Biol 2016
104
25

Regulation of Glioma Cells Migration by DYRK2.
Yifen Shen, Li Zhang, Donglin Wang, Yifeng Bao, Chao Liu, Zhiwei Xu, Wei Huang, Chun Cheng. Neurochem Res 2017
10
60

Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.
Sourav Banerjee, Chenggong Ji, Joshua E Mayfield, Apollina Goel, Junyu Xiao, Jack E Dixon, Xing Guo. Proc Natl Acad Sci U S A 2018
70
25

Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Shin-ichi Yamashita, Masao Chujo, Keita Tokuishi, Kentaro Anami, Michiyo Miyawaki, Satoshi Yamamoto, Katsunobu Kawahara. J Thorac Cardiovasc Surg 2009
12
50

Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Yuchan Wang, Yaxun Wu, Xiaobing Miao, Xinghua Zhu, Xianjing Miao, Yunhua He, Fei Zhong, Linlin Ding, Jing Liu, Jie Tang,[...]. Int J Biol Macromol 2015
12
41

Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR.
Rei Mimoto, Naoe T Nihira, Shinichi Hirooka, Hiroshi Takeyama, Kiyotsugu Yoshida. Cancer Lett 2017
13
38


Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.
Meera Soundararajan, Annette K Roos, Pavel Savitsky, Panagis Filippakopoulos, Arminja N Kettenbach, Jesper V Olsen, Scott A Gerber, Jeyanthy Eswaran, Stefan Knapp, Jonathan M Elkins. Structure 2013
97
20

Cep78 controls centrosome homeostasis by inhibiting EDD-DYRK2-DDB1VprBP.
Delowar Hossain, Yalda Javadi Esfehani, Arindam Das, William Y Tsang. EMBO Rep 2017
29
20

Multiple functions of DYRK2 in cancer and tissue development.
Saishu Yoshida, Kiyotsugu Yoshida. FEBS Lett 2019
20
25

Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
Tomotaka Kumamoto, Kohji Yamada, Saishu Yoshida, Katsuhiko Aoki, Shinichi Hirooka, Ken Eto, Katsuhiko Yanaga, Kiyotsugu Yoshida. Int J Oncol 2020
10
50



Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
Gabriella D'Orazi, Barbara Cecchinelli, Tiziana Bruno, Isabella Manni, Yuichiro Higashimoto, Shin'ichi Saito, Monica Gostissa, Sabrina Coen, Alessandra Marchetti, Giannino Del Sal,[...]. Nat Cell Biol 2002
554
16

Interaction between RNF8 and DYRK2 is required for the recruitment of DNA repair molecules to DNA double-strand breaks.
Takenori Yamamoto, Naoe Taira Nihira, Satomi Yogosawa, Katsuhiko Aoki, Hiroyuki Takeda, Tatsuya Sawasaki, Kiyotsugu Yoshida. FEBS Lett 2017
13
30

Drosophila Dyrk2 plays a role in the development of the visual system.
Nathan Luebbering, Mark Charlton-Perkins, Justin P Kumar, Pamela A Lochead, Stephanie M Rollmann, Tiffany Cook, Vaughn Cleghon. PLoS One 2013
9
44

Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs.
Pamela A Lochhead, Gary Sibbet, Nick Morrice, Vaughn Cleghon. Cell 2005
214
16

Dyrk2 mediated the release of proinflammatory cytokines in LPS-induced BV2 cells.
Li Xu, Yuxiang Sun, Mengmeng Li, Xin Ge. Int J Biol Macromol 2018
11
36

DYRK2 displays muscle fiber type specific function during zebrafish early somitogenesis.
Wei Sun, Shuang Jiao, Xungang Tan, Peijun Zhang, Feng You. Int J Dev Biol 2017
8
50

p38 Stabilizes Snail by Suppressing DYRK2-Mediated Phosphorylation That Is Required for GSK3β-βTrCP-Induced Snail Degradation.
Ki-Jun Ryu, Sun-Mi Park, Seung-Ho Park, In-Kyu Kim, Hyeontak Han, Hyo-Jin Kim, Seon-Hee Kim, Keun-Seok Hong, Hyemin Kim, Minju Kim,[...]. Cancer Res 2019
20
20

The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
Paula Moreno, Maribel Lara-Chica, Rafael Soler-Torronteras, Teresa Caro, Manuel Medina, Antonio Álvarez, Ángel Salvatierra, Eduardo Muñoz, Marco A Calzado. PLoS One 2015
14
28

Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2.
Su Sien Ong, Asli N Goktug, Ayesha Elias, Jing Wu, Darren Saunders, Taosheng Chen. Biochem J 2014
29
16

Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
Sourav Banerjee, Tiantian Wei, Jue Wang, Jenna J Lee, Haydee L Gutierrez, Owen Chapman, Sandra E Wiley, Joshua E Mayfield, Vasudha Tandon, Edwin F Juarez,[...]. Proc Natl Acad Sci U S A 2019
24
16

A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.
Chun Shik Park, Andrew H Lewis, Taylor J Chen, Cory S Bridges, Ye Shen, Koramit Suppipat, Monica Puppi, Julie A Tomolonis, Paul D Pang, Toni-Ann Mistretta,[...]. Blood 2019
26
16

The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis.
Saishu Yoshida, Katsuhiko Aoki, Ken Fujiwara, Takashi Nakakura, Akira Kawamura, Kohji Yamada, Masaya Ono, Satomi Yogosawa, Kiyotsugu Yoshida. Elife 2020
13
30

Epidemiology and management of liver metastases from colorectal cancer.
Sylvain Manfredi, Côme Lepage, Cyril Hatem, Olivier Coatmeur, Jean Faivre, Anne-Marie Bouvier. Ann Surg 2006
822
12

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.
Ann-Lii Cheng, Yoon-Koo Kang, Zhendong Chen, Chao-Jung Tsao, Shukui Qin, Jun Suk Kim, Rongcheng Luo, Jifeng Feng, Shenglong Ye, Tsai-Sheng Yang,[...]. Lancet Oncol 2009
12

Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.
Núria Bonifaci, Bohdan Górski, Bartlomiej Masojć, Dominika Wokołorczyk, Anna Jakubowska, Tadeusz Dębniak, Antoni Berenguer, Jordi Serra Musach, Joan Brunet, Joaquín Dopazo,[...]. PLoS One 2010
28
12

MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis.
Cinzia Rinaldo, Andrea Prodosmo, Francesca Mancini, Stefano Iacovelli, Ada Sacchi, Fabiola Moretti, Silvia Soddu. Mol Cell 2007
144
12





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.